Beta Drugs Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
455
- Stock Symbol
-
BETA
- Investments
-
3
- Share Price
-
$19.33
- (As of Friday Closing)
Beta Drugs General Information
Description
Beta Drugs Ltd is a specialty pharmaceutical company focused on oncology therapies and is among the key players in India's oncology market, with integrated manufacturing and R&D capabilities. Its product portfolio includes oncology formulations, oncology APIs, dermatology products, pharmaceutical intermediates, and IVF/women's healthcare products. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
Contact Information
Website
www.betadrugslimited.comCorporate Office
- Shop-cum-Office 184
- Sector-5
- Panchkula, Haryana 134114
- India
Corporate Office
- Shop-cum-Office 184
- Sector-5
- Panchkula, Haryana 134114
- India
Beta Drugs Stock Performance
As of 13-Nov-2026, Beta Drugs’s stock price is $19.33. Its current market cap is $196M with 10.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.33 | $19.62 | $10.89 - $29.44 | $196M | 10.1M | 40.4K | $0.53 |
Beta Drugs Financials Summary
As of 30-Sep-2026, Beta Drugs has a trailing 12-month revenue of $47.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 219,056 | 129,110 | 223,430 | 141,326 |
| Revenue | 47,916 | 43,550 | 42,853 | 35,720 |
| EBITDA | 10,877 | 8,681 | 8,410 | 7,263 |
| Net Income | 5,752 | 4,695 | 5,017 | 4,401 |
| Total Assets | 68,329 | 52,548 | 50,998 | 30,470 |
| Total Debt | 5,069 | 15,665 | 16,139 | 1,764 |
Beta Drugs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beta Drugs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Beta Drugs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Beta Drugs Investments & Acquisitions (3)
Beta Drugs’s most recent deal was a Merger/Acquisition with Nivian Life Sciences for . The deal was made on 22-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nivian Life Sciences | 22-May-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Adley Labs | 25-Oct-2019 | Merger/Acquisition | Drug Discovery | ||
| Beta UBK International | 01-Oct-2018 | Joint Venture | Pharmaceuticals |
Beta Drugs ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Beta Drugs Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nivian Life Sciences | Mumbai, India | 2024 |
Beta Drugs FAQs
-
When was Beta Drugs founded?
Beta Drugs was founded in 1985.
-
Where is Beta Drugs headquartered?
Beta Drugs is headquartered in Panchkula, India.
-
What is the size of Beta Drugs?
Beta Drugs has 455 total employees.
-
What industry is Beta Drugs in?
Beta Drugs’s primary industry is Pharmaceuticals.
-
Is Beta Drugs a private or public company?
Beta Drugs is a Public company.
-
What is Beta Drugs’s stock symbol?
The ticker symbol for Beta Drugs is BETA.
-
What is the current stock price of Beta Drugs?
As of 13-Nov-2026 the stock price of Beta Drugs is $19.33.
-
What is the current market cap of Beta Drugs?
The current market capitalization of Beta Drugs is $196M.
-
What is Beta Drugs’s current revenue?
The trailing twelve month revenue for Beta Drugs is $47.9M.
-
What is Beta Drugs’s annual earnings per share (EPS)?
Beta Drugs’s EPS for 12 months was $0.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
